Akina
Novum acquires MMC from Dubag
Novum Capital is investing from its debut fund and will merge the company with Crosscast
Unigestion's Euro Choice Secondary II hits €300m hard-cap
Fund attracts commitments from 59 LPs to hold a final close 20 months after its announcement
Picking a DACH mid-cap master
With so many proponents of the mid-cap space in the region, how do LPs decide on their allocations?
Akina to launch sixth fund-of-funds, targeting €550m
Akina Partners has registered its sixth fund-of-funds, Euro Choice VII
Unigestion acquires Akina in $6bn AUM merger
Merged group will have $6bn in assets under management and will trade under the Unigestion brand
Akina closes Euro Choice VI on €410m
Fund previously held interim closes on €180m and more than €200m before the final close
Akina holds interim closes on three Euro Choice funds
All three funds are expected to hold a final close by the end of the year
Akina promotes four to partner
Firm promotes Natalia Sigrist, Christian Böhler, Francesco Aldorisio, Viktor Speckinger
Strong valuations in Nordic region driving co-investments
With strong pricing in the Nordic countries, GPs are looking to co-invest in order to secure deals
New Akina co-investment fund reaches €50m first close
Akina usually invests €2-15m in companies valued between €25-500m
Akina holds third close for Euro Choice VI at €180m
Vehicle aiming for €300m final close in 2016
Swiss currency move: the potential impact on private equity
Cap removal does not lead to loss of interest
Akina closes Euro Choice Secondary on €224m
Fund launched in Q4 2013 with €200m target
Germany: Some boom amid the doom and gloom
Macroeconomic pressures are being felt in the local PE market, but there are some bright spots emerging
Akina holds interim close for Euro Choice Secondary
Fund will hold final close on 17 December
Prices rise as Spain enjoys newfound popularity
Attractive lending markets in southern Europe causing increased competition for assets and a hike in prices
Germany Report 2014
Download the latest unquote" Germany report featuring LP Q&As and data commentary
German PE activity still lacklustre, says Akina’s Böhler
Akina's Böhler speaks to unquote" about the low levels of deal activity in Germany
N+1 et al. sell Xanit Group to Vithas
N+1 backed the business in 2007
Akina’s Euro Choice Secondary holds €73.5m first close
News comes a few months after Euro Choice V final close
Akina promotes Ralf Gleisberg to partner
Ralf Gleisberg, Akina
DACH: Growth capital value up as traditional buyouts suffer
Growth capital deals are proving more popular with businesses in the region
Akina closes Euro Choice V on $372m
Firm is also fundraising for fund-of-funds Euro Choice Secondary
Rosetta leads CHF 60m round for Novimmune
Life sciences-focused Rosetta Capital has led a CHF 60m ($66m) series-B funding round for Swiss biotech Novimmune.